Promoter Vupparapalli Chandrasekhar Reddy sold 1,12,19,267 shares of Novelix Pharmaceuticals Limited for ₹62.83 Cr at ₹56.00 apiece via preferential allotment, decreasing his stake from 10.89% to 8.92%.
A pharmaceutical company established in 1994, Novelix Pharma operates across healthcare research, analytics, and technology sectors in India. The company engages in trading pharmaceuticals, related healthcare products, shares, and securities while providing research-driven solutions to support pharmaceutical development. Novelix combines analytical capabilities with technology infrastructure to serve the Indian healthcare and pharmaceutical industry, focusing on bridging research innovation with market-driven solutions.
